A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the safety, pharmacokinetics, pharmacodynamics and
efficacy of repeated once daily oral administration of D961H 10 mg and D961H 20 mg in
Japanese paediatric patients aged 1 to 14 years old who either have a diagnosis of or are
suspected to have gastric ulcer (GU), duodenal ulcer (DU), anastomotic ulcer (AU),
non-erosive reflux esophagitis disease (NERD), reflux esophagitis (RE) or Zollinger-Ellison
syndrome.